China Box Office: ‘Pegasus 3’ Stays Ahead as ‘GOAT’ Debuts

Pegasus 3 led the China box office with RMB77.7M ($10.9M) for the March 13–15 weekend and a cumulative total of $596.8M. Weekend grosses across mainland China were $33.5M and year-to-date revenue is $1.58B, down 52.9% year-over-year. Other notable results: Blades of the Guardians $5.8M weekend ($190.3M cumulative), Scare Out $4.3M weekend ($182.1M cumulative), GOAT debuted at $3.1M, and Boonie Bears added $2.5M ( $146.1M cumulative).

Analysis

China’s theatrical market is increasingly a winner-take-most environment: durable franchise IP and event tentpoles are capturing a larger share of sparse audience attention, leaving mid- and low-budget titles dependent on alternative monetization. That concentration gives top IP owners asymmetric pricing and licensing power — they can extract better theatrical splits, upstream streaming fees, and broader brand partnerships, while exhibitors’ per-screen economics and concession margins are the flexible variable that will absorb most downside.

For multinational studios, underperformance of localized releases exposes the limits of distribution as a growth lever; the structural response will be more co-productions, tighter release scheduling with domestic partners, and greater pre-sale/licensing of ancillary rights to protect revenue. Sony’s animated title performance is a stress-test for that strategy: marginal theatrical receipts in China will push more value into back-end streaming/licensing and merchandising rather than box office, pressuring near-term content ROI but leaving upside if IP scales across digital channels.

Catalysts that could reverse the current dynamic include government policy support for cultural consumption, a packed domestic tentpole calendar or concerted studio-led marketing campaigns that re-energize foot traffic; conversely, faster migration of families to SVOD/PVOD models would further compress theatrical elasticity. Timeline: tactical moves can play out over 3–9 months as slate schedules and promotional calendars change, while structural exhibitor FCF pressure and content window shifts are multi-quarter to multi-year phenomena.

Key Decisions for Investors

• Short China exhibition operators (e.g., 002739.SZ Wanda Film, 600977.SS China Film) — 3–6 month horizon. Thesis: continued revenue concentration and weaker midweek attendance compress free cash flow and raise refinancing/maintenance capex risk. Target 20–30% downside; stop-loss at 12% to limit regime-change risk if a successful tentpole season restores volumes.
• Long China-facing digital content plays that can monetize IP beyond theatrical (BILI) — 6–12 month horizon. Thesis: platforms capture licensing and long-tail viewership if theatrical windows shorten; asymmetric upside if content migration accelerates. Risk/reward: aim for 30–50% upside with downside limited to platform-specific execution risks; hedge with short position in an exhibitor.
• Buy short-dated put protection on SONY (3-month OTM puts ~5% strike distance) as an inexpensive hedge rather than directional bet. Rationale: Sony has diversified exposure, but incremental China softness lowers optional upside; puts cap portfolio delta to China content risk at limited premium. Position sizing: 1–2% notional of global media exposure.